O'Brien Greene & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
O'Brien Greene & Co's LLY Position: Q2 2026 in Review
O'Brien Greene & Co increased its Eli Lilly (LLY) stake by 2.8% in Q2 2026, buying an estimated $25.5K and bringing the position to 925 shares worth $1.11M. The position accounts for 0.31% of the portfolio, ranked #51.
O'Brien Greene & Co first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- O'Brien Greene & Co held 925 shares of Eli Lilly worth $1.11M as of Q2 2026.
- O'Brien Greene & Co bought 25 Eli Lilly shares in Q2 2026, an estimated $25.5K.
- Eli Lilly made up 0.31% of O'Brien Greene & Co's portfolio in Q2 2026, its #51 holding.
- O'Brien Greene & Co first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on O'Brien Greene & Co's 13F filing for Q2 2026, filed 6 Aug 2026.